The apex court has, however, refused to pass an interim order restraining Ranbaxy from manufacturing drugs
New Delhi: There is more trouble for pharma giant Ranbaxy. The Supreme Court has issued a notice to the company as well as the Centre on the basis of a petition that has sought a probe against Ranbaxy for allegedly supplying adulterated drugs in the country.
The apex court has, however, refused to pass an interim order restraining Ranbaxy from manufacturing drugs.
This comes just a week after Ranbaxy recalled more than 64,000 bottles of a cholestrol drug in the US due to a potential dose mix-up.
Comments
0 comment